VitriVax
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $17M
Investors
- 2
About VitriVax
Based in the US, VitriVax, Inc.VitriVax, Inc. was founded in 2017 and operates from Boulder, US. The company focuses on developing cutting-edge vaccination technology. In October 2025, VitriVax, Inc. The company offers a range of innovative products designed to address specific challenges across various industries. Their core product line includes advanced software solutions that streamline operational processes, enhance data analytics, and improve customer engagement. These offerings cater primarily to businesses in the technology, finance, and healthcare sectors, aiming to optimize performance and drive growth. The company has effectively positioned its services in key geographical markets, including North America, Europe, and parts of Asia, ensuring accessibility to a wide base of clients and end users.The company's revenue model is structured around direct sales and subscription-based services, allowing for a steady flow of income from both individual clients and larger enterprises. Transactions often occur through annual contracts for software licenses, with clients benefiting from tiered pricing based on the scale of their operations and the features they require. Flagship products, known for their unique capabilities, are priced competitively to attract a diverse clientele ranging from small businesses to multinational corporations. Partnerships with retailers and wholesalers further expand the company’s reach, facilitating direct access to end users while enhancing brand visibility. This structured approach to revenue generation positions the company favorably within the market, fostering long-term relationships with clients and ensuring sustainable growth.
Who invested in VitriVax
2 investors across 2 rounds
See all investors in VitriVax
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VitriVax
Who invested in VitriVax?
VitriVax has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VitriVax raised?
VitriVax has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did VitriVax last raise money?
VitriVax's most recent round on record is a Series B, in Oct 2025.
What does VitriVax do?
Based in the US, VitriVax, Inc.
Where is VitriVax headquartered?
VitriVax is headquartered in Boulder, US.
Which VCs invest in companies like VitriVax?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at VitriVax's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like VitriVax? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.